-+ 0.00%
-+ 0.00%
-+ 0.00%
PMV Pharma Presents Updated Phase 2 Rezatapopt Data at ENA Symposium
Share
Listen to the news
PMV Pharma Presents Updated Phase 2 Rezatapopt Data at ENA Symposium
  • PMV Pharmaceuticals will present pivotal Phase 2 rezatapopt trial results at ENA 2026 in Barcelona on November 20, 2026.
  • Alison M. Schram of Memorial Sloan Kettering Cancer Center will deliver the late-breaking oral presentation at 15:00 CET.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PMV Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611040800PRIMZONEFULLFEED9869695) on November 04, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending